ProShare Advisors LLC - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-61.3%
12,680
-19.6%
0.00%
Q4 2021$75,000
-39.5%
15,771
+0.7%
0.00%
Q3 2021$124,000
-7.5%
15,658
-18.8%
0.00%
Q2 2021$134,000
-9.5%
19,293
+3.2%
0.00%
Q1 2021$148,000
+8.0%
18,697
+7.5%
0.00%
-100.0%
Q4 2020$137,000
+57.5%
17,400
+41.0%
0.00%
Q3 2020$87,000
-26.9%
12,337
-3.9%
0.00%
-100.0%
Q2 2020$119,000
+43.4%
12,831
+18.8%
0.00%
Q3 2019$83,000
+15.3%
10,801
+3.3%
0.00%
Q2 2019$72,000
-21.7%
10,452
-8.4%
0.00%
-100.0%
Q1 2019$92,00011,4060.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Yu Fan 20,592$347,79824.67%
VR Adviser, LLC 295,034$3,614,1670.38%
IFP Advisors, Inc 2,860$1,7180.00%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders